BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Laryngoscope
,
Ciprofibrate
,
rs6983267
,
CXCL2
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ifn γ receptor 1
Summary
General Info
Curated Studies
Most Correlated Studies
Foreskin fibroblast BJ cells IFN-β, IFN-γ treatment or mutant STAT1 overexpression
Cerebral microvascular endothelial hCMEC/D3 cells treated with TNF-α and IFN-γ
Macrophages cultured from bone marrow of ATG5-deficient mice and treated with IFN-γ
Bone marrow derived DCs stimulated with γ-polyglutamic acid (PGA) NPs, LPS and unparticulate γ-PGA
Calu-3 cells responses to treatment with either IFN alpha or gamma
Explore Curated Studies Results
Literature
Most Relevant Literature
Melatonergic signalling instructs transcriptional inhibition of IFNGR2 to lessen interleukin-1β-depe…
Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-γR2 d…
Inherited human IFN-γ deficiency underlies mycobacterial disease.
Sex-dependent regulation of interferon-γ receptor expression in pulmonary tuberculosis.
Regulation of Interferon-γ receptor (IFN-γR) expression in macrophages during Mycobacterium tubercul…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Type I IFN Level and Disease Activity in SLE Patients
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ